IFP Advisors’s Evofem Biosciences, Inc. Common Stock EVFM Stock Holding History

IFP Advisors’s Portfolio EVFM Stock Details EVFM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-30	Closed	-$2K	–	4968
2022 Q3	$2K	Hold	30	–	–	﹤0.01%	4479
2022 Q2	$2K	Buy	30 +28	+1,400%	+$46	﹤0.01%	4257
2022 Q1	$2K	Buy	+2	New	+$13	﹤0.01%	4255
2020 Q4	–	Sell	-33	Closed	-$1.19K	–	3161
2020 Q3	$1K	Buy	+33	New	+$1.44K	﹤0.01%	2757

IFP Advisors's EVFM Position: Q4 2022 in Review

IFP Advisors sold out of Evofem Biosciences, Inc. Common Stock (EVFM) in Q4 2022, closing a stake of 30 shares — an estimated $2K sold.

IFP Advisors first reported a position in EVFM in Q3 2020 and held it in 4 quarters. The position peaked at $2K in Q3 2022. 0 funds tracked by Wall St. Rank hold EVFM as of Q4 2022.

IFP Advisors reported no remaining Evofem Biosciences, Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
IFP Advisors sold 30 Evofem Biosciences, Inc. Common Stock shares in Q4 2022, an estimated $2K.
IFP Advisors first reported a position in Evofem Biosciences, Inc. Common Stock in Q3 2020 and held it in 4 quarters.
IFP Advisors's Evofem Biosciences, Inc. Common Stock position peaked at $2K in Q3 2022.
0 funds tracked by Wall St. Rank held Evofem Biosciences, Inc. Common Stock as of Q4 2022.

Based on IFP Advisors's 13F filing for Q4 2022, filed 7 Feb 2023.